Wayne Gordon
General Counsel bei A-Bio Pharma Pte Ltd.
Profil
Wayne Gordon is Director of Regulatory Affairs and Quality for A-Bio Pharma Pte Ltd.
Prior to joining A-Bio Pharma in January 2008, he was a Senior Director of Quality for Tanox, Inc. Dr. A-Bio Pharma received a PhD in Physiology and Biophysics from the University of Illinois.
Aktive Positionen von Wayne Gordon
Unternehmen | Position | Beginn |
---|---|---|
A-Bio Pharma Pte Ltd.
A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | General Counsel | 01.01.2008 |
Ehemalige bekannte Positionen von Wayne Gordon
Unternehmen | Position | Ende |
---|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Corporate Officer/Principal | - |
Ausbildung von Wayne Gordon
University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
A-Bio Pharma Pte Ltd.
A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | Commercial Services |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |